Search research articles
Contact Us
Filters
Showing results (101-110 of 252) with videos related to
Page
of 26
Sort By:
British Journal of Haematology
|
January 24, 2021
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group
Dennis A Eichenauer, Horst Müller, Leonard Elger, et al.
Blood
|
September 1, 2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
Carsten Kobe, Helen Goergen, Christian Baues, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2017
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials
Stephanie Sasse, Paul J Bröckelmann, Helen Goergen, et al.
Blood
|
June 17, 2010
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
Teresa V Halbsguth, Lucia Nogová, Horst Mueller, et al.
Leukemia & Lymphoma
|
October 22, 2013
Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant
Bastian von Tresckow, Horst Müller, Dennis A Eichenauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 9, 2018
Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Jasmin Mettler, Horst Müller, Conrad-Amadeus Voltin, et al.
European Journal of Haematology
|
March 22, 2005
Imaging of central nervous system lymphomas with iodine-123 labeled rituximab
Markus Dietlein, Hendrik Pels, Holger Schulz, et al.
Haematologica
|
August 26, 2003
Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas
Peter Borchmann, Franck Morschhauser, Anne Parry, et al.
Leukemia
|
May 13, 2025
Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
Dennis A Eichenauer, Aylin Basaran, Ina Bühnen, et al.
British Journal of Haematology
|
June 20, 2020
How I treat advanced Hodgkin lymphoma - a global view
Peter Hokland, Mansi Shah, Kevin David, et al.
Page
of 26
Search research articles
Search
Showing results (101-110 of 252) with videos related to
Sort By:
Page
of 26
British Journal of Haematology
|
January 24, 2021
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group
Dennis A Eichenauer, Horst Müller, Leonard Elger, et al.
Blood
|
September 1, 2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
Carsten Kobe, Helen Goergen, Christian Baues, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2017
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials
Stephanie Sasse, Paul J Bröckelmann, Helen Goergen, et al.
Blood
|
June 17, 2010
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
Teresa V Halbsguth, Lucia Nogová, Horst Mueller, et al.
Leukemia & Lymphoma
|
October 22, 2013
Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant
Bastian von Tresckow, Horst Müller, Dennis A Eichenauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 9, 2018
Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Jasmin Mettler, Horst Müller, Conrad-Amadeus Voltin, et al.
European Journal of Haematology
|
March 22, 2005
Imaging of central nervous system lymphomas with iodine-123 labeled rituximab
Markus Dietlein, Hendrik Pels, Holger Schulz, et al.
Haematologica
|
August 26, 2003
Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas
Peter Borchmann, Franck Morschhauser, Anne Parry, et al.
Leukemia
|
May 13, 2025
Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
Dennis A Eichenauer, Aylin Basaran, Ina Bühnen, et al.
British Journal of Haematology
|
June 20, 2020
How I treat advanced Hodgkin lymphoma - a global view
Peter Hokland, Mansi Shah, Kevin David, et al.
Page
of 26